Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients.
Saved in:
| Title: | Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients. |
|---|---|
| Authors: | Park HA; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty, University of Heidelberg, Heidelberg, Germany., Edelmann D; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Harrison TA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Hua X; Department of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Cardiology, Peking University Third Hospital, Peking University, Beijing, China., Shi Q; Department of Quantitative Science, Mayo Clinic, Rochester, Minnesota, USA., Silverman A; Epidemiology Program, Fred Hutchinson Research Cancer Research Center, Seattle, Washington, USA., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Macauda A; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schneider M; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Goldberg RM; West Virginia University Cancer Institute, Morgantown, West Virginia, USA., Alberts SR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Chan AT; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Peters U; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; School of Public Health, University of Washington, Seattle, Washington, USA., Newcomb PA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; School of Public Health, University of Washington, Seattle, Washington, USA., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. |
| Source: | International journal of cancer [Int J Cancer] 2023 Nov 01; Vol. 153 (9), pp. 1623-1634. Date of Electronic Publication: 2023 Aug 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0215 |
|---|---|
| DOI: | 10.1002/ijc.34663 |
